electroCore Presentation at the Cantor Fitzgerald Virtual Global Healthcare Conference

On September 30, 2021, electroCore, Inc. (NASDAQ: ECOR) announced the rescheduling of its presentation at the Cantor Fitzgerald Virtual Global Healthcare Conference to the same day at 12:40 PM EDT.

Rhea-AI Summary

On September 30, 2021, electroCore, Inc. (NASDAQ: ECOR) announced the rescheduling of its presentation at the Cantor Fitzgerald Virtual Global Healthcare Conference to the same day at 12:40 PM EDT. Investors interested in the presentation can register for the conference through the provided link. Following the event, a replay of the webcast will be available on the company's investor section of its website. electroCore focuses on bioelectronic medicine, particularly using non-invasive vagus nerve stimulation for treating various neurological conditions.

Positive

• Company presentation rescheduled at a prominent healthcare conference, enhancing visibility.
• Focus on bioelectronic medicine with potential for significant market impact.

Negative

• None.

Argus Session date unavailable

+0.89% session move Open Argus

Details

News Market Reaction – ECOR

The recorded move for ECOR in the trading session of this news was +0.89%.

Data tracked by StockTitan Argus. Session date unavailable.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

ROCKAWAY, NJ, Sept. 30, 2021 (GLOBE NEWSWIRE) -- electroCore, Inc. (the “Company”), (NASDAQ: ECOR), a commercial-stage bioelectronic medicine company, today announced that its presentation at the Cantor Fitzgerald Virtual Global Healthcare Conference has been rescheduled to today, September 30, 2021 at 12:40 PM eastern time. 

Details for the company’s presentation are as follows:

Cantor Fitzgerald Virtual Global Healthcare Conference:
Date: Thursday, September 30, 2021
Rescheduled Time: 12:40 pm EDT
Investors can register for the conference HERE.

Following the conference a webcast replay of the presentation will be available on the Investor section of the company’s website, www.electrocore.com.

About electroCore, Inc.
electroCore, Inc. is a commercial stage bioelectronic medicine company dedicated to improving patient outcomes through its non-invasive vagus nerve stimulation therapy platform, initially focused on the treatment of multiple conditions in neurology. The company's current indications are the preventive treatment of cluster headache and migraine and the acute treatment of migraine and episodic cluster headache.
For more information, visit www.electrocore.com.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What is the date of electroCore's presentation at the Cantor Fitzgerald Conference?

The presentation is scheduled for September 30, 2021.

What time is electroCore's presentation at the Cantor Fitzgerald Conference?

The presentation will take place at 12:40 PM EDT.

How can I access the webcast of electroCore's conference presentation?

A replay of the webcast will be available on the investor section of electroCore's website after the presentation.

What is electroCore's focus in the bioelectronic medicine space?

The company is focused on non-invasive vagus nerve stimulation therapy for treating conditions like cluster headaches and migraines.